Adma Biologics Inc logo

ADMA

Adma Biologics Inc

$11

Earnings Summary

Revenue
$81.88Mn
Net Profits
$17.81Mn
Net Profit Margins
21.75%

Highlights

Revenue:

Adma Biologics Inc’s revenue jumped 43.86% since last year same period to $81.88Mn in the Q1 2024. On a quarterly growth basis, Adma Biologics Inc has generated 10.79% jump in its revenue since last 3-months.

Net Profits:

Adma Biologics Inc’s net profit jumped 239.5% since last year same period to $17.81Mn in the Q1 2024. On a quarterly growth basis, Adma Biologics Inc has generated 200.92% jump in its net profits since last 3-months.

Net Profit Margins:

Adma Biologics Inc’s net profit margin jumped 196.97% since last year same period to 21.75% in the Q1 2024. On a quarterly growth basis, Adma Biologics Inc has generated 191.09% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Adma Biologics Inc post its latest quarter earnings

EPS Estimate Current Quarter
0.08
EPS Estimate Current Year
0.08

Highlights

EPS Estimate Current Quarter:

Adma Biologics Inc’s earning per share (EPS) estimates for the current quarter stand at 0.08 - a 33.33% jump from last quarter’s estimates.

EPS Estimate Current Year:

Adma Biologics Inc’s earning per share (EPS) estimates for the current year stand at 0.08.

Key Ratios

Key ratios of the Adma Biologics Inc post its Q1 2024 earnings

Earning Per Share (EPS)
0.08
Return on Assets (ROA)
0.09
Return on Equity (ROE)
-0.02

Highlights

Earning Per Share (EPS):

Adma Biologics Inc’s earning per share (EPS) jumped 366.67% since last year same period to 0.08 in the Q1 2024. This indicates that the Adma Biologics Inc has generated 366.67% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Adma Biologics Inc’s return on assets (ROA) stands at 0.09.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Adma Biologics Inc’s return on equity (ROE) stands at -0.02.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2024-05-09
0.06
0.08
33.33%